Inovio Pharmaceuticals Inc (INO)

[pistol1p]

The run up to the phase 2 data release, was imho, limited and most of the pps increase happened in the last week or two. Stock could have been purchase on 7/17 for $9.29.

R/S pps: $9.20
Yesterdays close: $11.14

You may be right about the "sell the news", with a little AF shorting as well, but with the relatively small pre-data run up, I think INO will move higher and back in the $14-$15 range very shortly.

The data is good and should lead to phase 3 and a likely partnership.